Loading...
XSAU
2070
Market cap918mUSD
Nov 12, Last price  
28.88SAR
Name

Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC

Chart & Performance

D1W1MN
XSAU:2070 chart
P/E
140.49
P/S
2.05
EPS
0.21
Div Yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
1.62%
Revenues
1.68b
+1.75%
727,838,041797,748,000871,939,000950,741,0001,037,640,9801,129,218,0821,244,904,5361,296,623,0731,470,185,8271,705,050,8881,841,194,3471,386,041,5241,274,819,4881,552,515,0781,559,477,0281,459,783,9691,426,337,0881,653,084,0001,682,000,000
Net income
25m
P
99,149,729121,864,000128,269,000154,804,000176,524,996211,433,264232,632,902266,820,753316,853,033357,053,878376,691,747197,365,535102,828,944-481,072,349124,787,29526,454,090-170,231,771-13,711,00024,535,000
CFO
-331m
L
99,670,858120,234,000109,295,000124,450,000135,981,552108,818,580147,583,943157,749,67943,238,950-38,468,7179,408,046155,344,481-80,503,165349,990,8909,735,67986,712,689-124,198,13247,734,000-331,000,000
Dividend
Jun 09, 20220.6 SAR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Saudi Pharmaceutical Industries and Medical Appliances develops, manufactures, and markets medicinal products and pharmaceutical formulations in the Kingdom of Saudi Arabia, Egypt, the Middle East, Morocco, and Algeria. The company is also involved in the manufacturing of basic chemical substances and products; medicines for human use, including cosmetics; and wholesale and retail of medicines and related products. In addition, it develops, manufactures, and sells pharmaceutical products and medical appliances; operates and maintains healthcare facilities. Further, the company engages in the research and development of medical science. The company was founded in 1986 and is headquartered in Buraydah, the Kingdom of Saudi Arabia.
URL
https://spimaco.com.sa/
IPO date
Jan 01, 1994
Employees
Domiciled in
SA
Incorporated in
SA

Valuation

Title
SAR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT